Research Library

The authors examine a new methodology from the National Academy of Medicine that could inform social, ethical and legal governance frameworks for a range of cutting-edge technologies. Read more at Issues in Science and Technology.

The authors articulate an approach for reducing COVID-19 vaccine inequity through globally distributed manufacturing of vaccines. Read the commentary published in The Lancet.

A study found that private equity acquisition of hospitals had no substantial association with the patient-level outcomes examined, although it was associated with a moderate improvement in mortality among Medicare beneficiaries hospitalized with acute myocardial infarction.

A study of U.S. hospitals acquired by private equity firms found improved financial performance — and that patient throughput (or the process of admitting, treating and discharging patients) increased while staffing decreased.

This study finds that Maryland's all-payer model for healthcare comparatively lowered the risk of complications from surgery, as well as reducing increases in associated costs.

Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?

Private equity investment in hospitals has grown substantially in the 21st century, and it accelerated in the years leading up the COVID-19 pandemic. In this study of short-term acute care hospitals acquired by private equity firms, the authors find they not only have higher markups and profit margins, they’re also slower to expand their staffs.

The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal

It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.